General Information of the Protein
| Protein ID |
PT02883
|
||||
|---|---|---|---|---|---|
| Protein Name |
Superoxide dismutase [Cu-Zn]
|
||||
| Secondarily Protein Name |
Superoxide dismutase 1
|
||||
| Gene Name |
SOD1
|
||||
| Sequence |
MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Enzyme
|
||||
| Function |
Destroys radicals which are normally produced within the cells and which are toxic to biological systems.
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Cytoplasm
Mitochondrion
Nucleus
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000868 , PC12
Clinical Information about the Protein
Target 1 ( Superoxide dismutase Cu-Zn (SOD Cu-Zn) )
| Target Type | Clinical trial Target | ||||
|---|---|---|---|---|---|
| Disease | 1 Target-related Disease | 1 | |||
| 1 | Spinal cord injury [ICD-11: ND51.2] | ||||
| Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
| 1 | Tempol | Phase 2 | |||
Target 2 ( SOD1 messenger RNA (SOD1 mRNA) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|